Profectus BioSciences Inc., a leader in developing next generation vaccines for high value targets in biodefense, infectious, and emerging diseases, presented on the development of its rVSV-vectored Ebola and Marburg virus vaccine at the Filovirus Medical Countermeasures Workshop held in the National Institutes of Health Fishers Lane Conference ... (more)
http://www.businesswire.com/news/topix/20130924005331/en
http://www.businesswire.com/news/topix/20130924005331/en
No comments:
Post a Comment